Basics Keros Therapeutics, Inc. IPO Date: April 8, 2020 Sector: Healthcare Industry: Biotech Market Cap: $633.19M Activated in VL: True Average Daily Range Avg Daily Range: $1.18 | 2.69% Avg Daily Range (30 D): $0.25 | 1.75% Avg Daily Range (90 D): $0.21 | 1.50% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .45M Trade Size Avg Trade Size (Sh.): 59 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 1,925 Avg Inst. Trade: $1.88M Avg Inst. Trade (30 D): $1.15M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.93M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $1.16M Avg Closing Volume: 54.03K     News May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc. May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Apr 11, 2025 @ 6:35 PM Deal Dispatch: Harley-Davidson To Wipe Out? Plus, ... Source: Anthony Noto Apr 10, 2025 @ 5:51 PM Keros Therapeutics Goes Up For Sale On Heels Of St... Source: Vandana Singh Feb 28, 2025 @ 10:00 PM Keros Therapeutics Announces Participation at Upco... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $.37 $-.76 $3.66 Diluted EPS $.33 $-.76 $3.62 Revenue $ 232.79M $ 18.17M $ 211.19M Gross Profit $ $ $ Net Income / Loss $ 18.77M $ -30.7M $ 148.45M Operating Income / Loss $ .31M $ -39.82M $ 152.04M Cost of Revenue $ $ $ Net Cash Flow $ 284.59M $ -30.33M $ 160.61M PE Ratio 47.24